Supernus Pharmaceuticals SUPN
$28.61 +$0.26 (+0.92%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $28.00 -2.13%
Open$28.39
Prev close$28.35
Day range$28.15 – $29.51
Volume2.83M
Market cap$5.94B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts6
Average target$52.60+83.9% vs. price
- Buy 83%
- Hold 17%
Low $37.00Now $28.61Avg $52.60High $87.00
Recent rating changes
The last 20 actions on file set price targets from $37.00 to $87.00, averaging $59.83.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 9 Nov 2026 | BofA Securities | BUY | $47.00 |
| 4 Nov 2026 | Piper Sandler | BUY | $47.00 |
| 4 Nov 2026 | Stifel | HOLD | $37.00 |
| 3 Nov 2026 | Cantor Fitzgerald | BUY | $87.00 |
| 30 Oct 2026 | BofA Securities | BUY | – |
| 30 Oct 2026 | Stifel | HOLD | $55.00 |
| 28 Oct 2026 | Barclays | BUY | $45.00 |
| 21 Oct 2026 | TD Cowen | BUY | $65.00 |
| 15 Oct 2026 | BofA Securities | BUY | $55.00 |
| 12 Oct 2026 | BofA Securities | BUY | $60.00 |
| 17 Sep 2026 | Craig-Hallum | BUY | – |
| 3 Aug 2026 | TD Cowen | BUY | $65.00 |
| 27 Jul 2026 | Piper Sandler | BUY | $66.00 |
| 13 Jul 2026 | BofA Securities | BUY | $63.00 |
| 9 Jul 2026 | Cantor Fitzgerald | BUY | $67.00 |
| 4 Jun 2026 | Piper Sandler | BUY | $66.00 |
| 6 May 2026 | Piper Sandler | BUY | $66.00 |
| 6 May 2026 | Stifel | HOLD | $55.00 |
| 5 May 2026 | TD Cowen | BUY | $65.00 |
| 27 Apr 2026 | Piper Sandler | BUY | $66.00 |
No comments yet — be the first to weigh in on SUPN.
Sign in to join the discussion.